Corner Therapeutics

📍 Watertown, United States🗓 Founded 2020👥 32 employees💰 Last funded Jan 2022
Biotechnology Research🌐 cornertx.com
Website LinkedIn
Corner is pioneering a new class of immunotherapies. Our versatile dendritic cell hyperactivation (hDC) platform is unique in its ability to address a virtually unbounded range of cancers and infectious diseases. Our platform technology induces exceptional memory T cell responses that provide robust and durable immunity. Corner seeks to transform standard of care, ushering in a new era of robust, rapid, patient-friendly and low-cost immunotherapies – even for the most difficult to treat diseases.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Corner Therapeutics?
Corner Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Corner Therapeutics last raise funding?
The most recent investment in Corner Therapeutics recorded on gritt.io was in January 2022.
When was Corner Therapeutics founded?
Corner Therapeutics was founded in 2020.
What industry is Corner Therapeutics in?
Corner Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Corner Therapeutics based?
Corner Therapeutics is headquartered in Watertown, United States.